Weitzman Deborah
CIK 0001942639
CEO, Pharmaceutical Segment
Filings
12
Latest Dec 2, 2025
Issuers covered
1
Showing
12 of 12
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 100% | +3.1% | +2.2% | +5.3% | +1.9% |
| 90 days | 3 | 0% | -19.2% | -18.8% | -3.4% | -35.3% |
| 180 days | 3 | 33% | -19.7% | -22.9% | +11.2% | -47.5% |
| 365 days | 2 | 0% | -18.7% | -18.7% | -14.8% | -22.7% |
Issuers
Companies where Weitzman Deborah has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CAH | Cardinal Health Inc | 12 | Dec 2, 2025 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|